SYSCHEM (INDIA)
|
SYSCHEM (INDIA) Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.69 | 1.42 | -0.73 | -2.58 | -0.99 |
| CEPS(Rs) | 1.39 | 2.08 | 0.34 | -1.37 | 0.15 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 14.29 | 6.99 | 2.60 | 3.25 | 5.23 |
| Tax Rate(%) | 32.86 | 26.62 | 21.44 | 23.91 | 15.78 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 2.99 | 6.63 | 0.86 | -6.93 | -0.14 |
| EBIT Margin(%) | 1.87 | 4.75 | -2.88 | -9.76 | -2.48 |
| Pre Tax Margin(%) | 1.76 | 4.72 | -3.31 | -9.83 | -2.50 |
| PAT Margin (%) | 1.18 | 3.46 | -2.60 | -7.48 | -2.11 |
| Cash Profit Margin (%) | 2.38 | 5.53 | 1.33 | -4.32 | 0.34 |
| Performance Ratios | |||||
| ROA(%) | 2.18 | 6.17 | -2.64 | -8.28 | -3.06 |
| ROE(%) | 6.97 | 31.84 | -26.16 | -66.17 | -17.24 |
| ROCE(%) | 10.74 | 38.00 | -12.18 | -29.75 | -8.22 |
| Asset Turnover(x) | 1.84 | 1.78 | 1.01 | 1.11 | 1.45 |
| Sales/Fixed Asset(x) | 3.98 | 2.31 | 1.23 | 1.52 | 1.94 |
| Working Capital/Sales(x) | 7.89 | 8.36 | -32.90 | 59.78 | -11.68 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.25 | 0.43 | 0.81 | 0.66 | 0.52 |
| Receivable days | 86.28 | 63.36 | 25.19 | 38.25 | 31.63 |
| Inventory Days | 52.30 | 48.51 | 145.69 | 131.91 | 91.67 |
| Payable days | 141.13 | 124.77 | 239.03 | 208.88 | 167.59 |
| Valuation Parameters | |||||
| PER(x) | 86.73 | 31.05 | - | - | - |
| PCE(x) | 43.15 | 21.14 | 30.67 | -5.03 | 47.99 |
| Price/Book(x) | 4.20 | 6.84 | 4.43 | 2.31 | 1.45 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.21 | 1.35 | 0.48 | 0.44 | 0.40 |
| EV/Core EBITDA(x) | 33.52 | 17.26 | 40.71 | -6.11 | -939.60 |
| EV/EBIT(x) | 54.94 | 24.79 | -14.90 | -4.13 | -13.99 |
| EV/CE(x) | 4.18 | 6.42 | 0.50 | 0.41 | 0.50 |
| M Cap / Sales | 1.21 | 1.34 | 0.45 | 0.24 | 0.19 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 74.94 | 92.47 | -13.86 | -10.96 | -17.38 |
| Core EBITDA Growth(%) | -19.57 | 1,186.21 | 114.10 | - | -100.89 |
| EBIT Growth(%) | -29.50 | 427.83 | 73.98 | -232.64 | -244.05 |
| PAT Growth(%) | -38.81 | 364.36 | 69.33 | -200.36 | -346.29 |
| EPS Growth(%) | -51.05 | 293.07 | 71.63 | -162.01 | -346.29 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.07 | 0.29 | 2.17 | 1.68 |
| Current Ratio(x) | 1.31 | 1.36 | 0.92 | 1.03 | 0.81 |
| Quick Ratio(x) | 0.77 | 1.00 | 0.17 | 0.22 | 0.27 |
| Interest Cover(x) | 17.28 | 147.10 | -6.65 | -131.04 | -121.92 |
| Total Debt/Mcap(x) | - | 0.01 | 0.07 | 0.94 | 1.16 |
Compare Financial Ratios of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹160.3 Cr | 3.1% | 4.3% | -20.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
| CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | 3.1% |
4.3% |
-20.3% |
| SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses
